Minimize Hair Loss
Comfortably. Conveniently. Confidently.

Cancer patients undergoing chemotherapy have faced the almost inevitable prospect of losing their hair. While scalp cooling during chemotherapy has long been known as an effective method to help to prevent that hair loss,  until recently patients in the U.S. did not have access to an FDA-cleared scalp cooling treatment.

In 2015 the FDA gave clearance to The DigniCap® Scalp Cooling System. It is now indicated to reduce the liklihood of chemotherapy-induced alopecia in cancer patients with solid tumor cancers.

For over a decade, DigniCap® has successfully helped thousands of patients outside the United States. Now, with FDA clearance, infusion centers across the country will be able to offer this important treatment option directly to U.S. patients as part of their chemotherapy treatment.

DigniCap® is already available in many infusion centers across the country, with more being added every week.  Patients should talk with their physicians and infusion centers in their area to explore adding the DigniCap® treatment to their chemotherapy regimen. Click here for an updated of list of infusion centers offering the DigniCap®.

Featured Content from The Journal of the American Medical Association Network

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer   JAMA Feb 14, 2017  by Hope S. Rugo, MD; Paula Klein, MD, Susan Anitra Melin, MD; et al

Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come   JAMA Feb 14, 2017 by Dawn L. Hershman, MD MS

Do the Data on Scalp Cooling for Patients with Breast Cancer Warrant Broad Adoption? JAMA Feb 14, 2017 by Howard (Jack) West, MD

Chemotherapy and Hair Loss: JAMA Patient Page   JAMA Feb 14, 2017 by Christopher Muth, MD

Download the DigniCap App